The most recently added documents are listed below. To narrow down the results into the key area you are interested in, select the relevant term and press search. You can narrow the results further by selecting more terms. Untick a selected box to remove that filter or click reset to start over.
In a trachoma hyperendemic region, a TF prevalence <5% was successfully maintained in five districts for ≥2 years after stopping MDA. MDA is still not warranted for these districts, however, the S, F and E components of the SAFE strategy should continue.
GET2020 data for Trachoma Free Africa countries
This study investigated the impact of two round of mass drug administration on trachoma prevalence in Plateau and Nasarawa States of Nigeria.
Key messages from the 2018 GET2020 database as at 17 April 2018
This graph shows the total doses on Zithromax shipped to trachoma elimination programmes from 1999-2018
This timeline highlights important dates in the history of the global program to eliminate trachoma.
Updated GET2020 trachoma data for the WHO Western Pacific Region as at 17 April 2018.
Updated GET2020 trachoma data for the WHO South-East Asia Region as at 17 April 2018.